In our previous report, a hybrid peptide was designed by the fusion of an amphipathic α-helical peptide with an NPC-specific therapeutic peptide, to interact with phospholipids, and it was self-assembled into sub-30-nm lipid nanoparticles (named as α-NTP-LNs) that exhibited promising therapeutic effects on NPC tumors and metastases [20]. Here, HOXA7 is linked to nasopharyngeal carcinoma.